12
32
38
50
e E d i t i o n : A u g u s t 2 0 2 3 - I s s u e 8 - Vo l u m e 4
CHIEF EDITOR Rahul Koul
EDITORIAL Sachin Arya Special Correspondent
Vaishnavi Srivastava Reporter
Brijesh Kumar News Desk
Shanu K Art Direction & Cartoon
BUSINESS HEAD Bhaskar Jha
OPERATIONS Arvind Kumar Executive Oprations
Barun Dey Admin Executive
For advertinsing & marketing write to us : advertising @ biovoicenews . com
Disclaimer : Views and opinions expressed in this e- magazine are not necessarily those of BioVoice News and its publisher PetriDish Media Pvt . Ltd . and / or editors . We , at PetriDish Media Pvt . Ltd . do our best to verify the information published , but do not take responsibility for the absolute accuracy of the information contained in this publication . PetriDish Media Pvt . Ltd . does not accept responsibility for any business or any other decisions taken by the readers on the basis of the information provided herein . All rights reserved . No part of this publication should be reproduced by any means without the written permission from the publisher . Published by : PetriDish Media Pvt . Ltd ., B-1 / 6 , LGF , Hauz Khas , New Delhi – 110016 , INDIA
12
32
38
50
COVER STORY
Hits & Misses of Stormy Monsoon session
Six bioscience related bills OKAYED - Two key bills CAUGHT IN CONUNDRUM
As the Modi government inches towards completion of its second term in 2024 , the current monsoon session also assumed much significance for the bioscience policymaking .
INTERVIEW
“ Novozymes aspires to be 100 % renewable by 2030 ”
Krishna Mohan Puvvada , Vice President- Middle East , Africa & India , Novozymes-South Asia provides insights into the latest happenings within the company , emerging industry trends , new initiatives , future plans and much more .
INTERVIEW
“ Scientists need to embrace a problemsolving mindset ”
Dr Radha Rangarajan , Director , Central Drug Research Institute ( CSIR-CDRI ), Lucknow shared her views on the initiatives at the institute , industry academia interactions , technological trends , biopharma industry and much more .
INTERVIEW
“ Telemedicine anticipated to generate about US $ 5.5 billion in revenue by 2025 ”
Vikram Thaploo , CEO-Telehealth , Apollo Hospitals shares his vision for telehealth in India , Apollo ’ s initiatives and experiences , besides growth opportunities and upcoming trends in the segment .
04
BioVoiceNews | August 2023